India  

Some community spread in hotspots: AIIMS chief

IndiaTimes Monday, 6 April 2020
There may be some community spread of Covid-19 in hotspots and these areas need to be monitored closely to prevent community transmission of the virus, AIIMS director Dr Randeep Guleria said on Monday. β€œWhat the AIIMS director has said is not in variance with what we have been explaining,” health ministry joint secretary Lav Agarwal said.
0
shares
ShareTweetSavePostSend
 

πŸ’‘ newsR Knowledge: Other News Mentions

Randeep Guleria Randeep Guleria Indian pulmonologist

India's growth in COVID cases not as high as other countries: AIIMS Director [Video]

India's growth in COVID cases not as high as other countries: AIIMS Director

All India Institute of Medical Sciences Director Randeep Guleria on June 27 reacted on surging COVID-19 cases in the country. He said that the rise in COVID cases in country are not that high if compared to countries affected from the invisible enemy and India has low mortality rate. He said, "Rise in cases in India is still not as high as compared to other countries. In US, there've been almost 40,000 cases per day in last 2 days, our numbers aren't that high. Cases per million population continue to be low and we still have low mortality rate."

Credit: ANI    Duration: 01:37Published
India has very low COVID-19 cases for per million population: AIIMS Director [Video]

India has very low COVID-19 cases for per million population: AIIMS Director

The Director of All India Institute of Medical Sciences, (AIIMS), Dr Randeep Guleria said on June 12 that India is still very low in terms of number of cases of coronavirus, if one looks at number of cases per million population. "Although India has gone up to the 4th rank as far as COVID-19 cases are concerned, we have to accept that it is because of the population we have. If we look at number of cases per million population, we still are very low in terms of number of cases," said Dr Randeep Guleria.

Credit: ANI    Duration: 01:13Published
Delhi may not see 5.5 lakh corona cases by July 31, but we need to be ready: AIIMS Director [Video]

Delhi may not see 5.5 lakh corona cases by July 31, but we need to be ready: AIIMS Director

The Director of All India Institute of Medical Sciences, (AIIMS), Dr Randeep Guleria reacted over Delhi's Deputy Chief Minister Manish Sisodia's statement that 5.5 lakh cases are expected in the national capita by July 31. "Number of cases in Delhi may not be as high as predicted but still whatever be the number, we have to increase our capacity so that we can manage increasing load that healthcare system is going to get," he said.

Credit: ANI    Duration: 01:09Published
Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug [Video]

Amid HCQ row, AIIMS Director explains two 'different aspects' of using the anti-malarial drug

Director of All India Institute of Medical Sciences (AIIMS) Delhi, Dr Randeep Guleria said that there are higher chances of toxicity if Hydroxychloroquine (HCQ) used as part of treatment for severe COVID-19 patients because of multiple drugs being used. Being asked about his opinion on WHO 'temporarily' suspending clinical trials of HCQ for COVID-19, Dr Guleria said, "There are 2 different aspects, using Hydroxychloroquine as part of treatment for severe COVID-19 patients has higher chance that you may have toxicity because of multiple drugs being used. And there are certain drugs which along with hydroxychloroquine can increase the chance of cardiac toxicity. On the other hand, when we are giving it as prophylaxis or in mild illness and giving it alone the chances of side effects are much less. We, as physicians have been using hydroxychloroquine for almost 30-40 years. Patients have been using it daily, not for week but for months and years with no side effects. So, when it is used judiciously, appropriately and not in combination with other drugs where the side effects can become much more, there is good suggestive data that suggests it is useful."

Credit: ANI    Duration: 01:26Published

All India Institute of Medical Sciences, New Delhi All India Institute of Medical Sciences, New Delhi Medical School,Hospital and Public Medical Research University based in New Delhi,India

Bodies of 2 COVID patients swapped at AIIMS [Video]

Bodies of 2 COVID patients swapped at AIIMS

Dead bodies of two patients belonging to two different communities were swapped at All India Institute of Medical Sciences (AIIMS) on July 06. Daughter of the deceased said, "We received a call from AIIMS, and the staff member told us that by mistake they have given someone else's body to us. My mother's body was still in the hospital. The body which we received belonged to a Muslim family." The body of the Muslim woman was cremated following Hindu customs.

Credit: ANI    Duration: 01:46Published

Bodies of two COVID positive patients swapped at AIIMS, Muslim woman cremated by another family

The shocking incident of negligence came to light on Tuesday as the bodies of two COVID-19 victims belonging to two different communities were swapped at..
DNA

Bodies of two COVID patients swapped at AIIMS, Muslim woman cremated by another family

The shocking incident of negligence came to light on Tuesday as the bodies of two COVID-19 victims belonging to two different communities were swapped at..
DNA

Coronavirus disease 2019 Coronavirus disease 2019 Infectious respiratory disease caused by severe acute respiratory syndrome coronavirus 2

Mumbai: 100-year-old man recovers from COVID-19; centenarian thanks hospital on discharge before 101st birthday

He was discharged from the Hindu Heart Emperor Hospital last night.
DNA
Early results show Moderna vaccine is safe [Video]

Early results show Moderna vaccine is safe

Moderna's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers reported on Tuesday. Libby Hogan reports.

Credit: Reuters Studio    Duration: 01:35Published

India's Zydus begins human trials for potential Covid-19 vaccine

Indian pharmaceutical company Zydus said on Wednesday it has started human studies for its potential Covid-19 vaccine. ​​ZyCoV-D, its plasmid DNA vaccine,..
IndiaTimes
Fans perform 'yagna' in WB's Asansol for speedy recovery of Amitabh Bachchan from COVID-19 [Video]

Fans perform 'yagna' in WB's Asansol for speedy recovery of Amitabh Bachchan from COVID-19

The fans of Bollywood actor Amitabh Bachchan organised 'yagna' in West Bengal's Asansol and prayed for his speedy recovery from COVID-19. One of his fan said, "We are upset that Amitabh ji has contracted the infection. We pray that everyone including him recovers soon." Amitabh Bachchan was tested COVID-19 positive on July 11. Later, Abhishek Bachchan, Aishwarya Rai and their daughter Aaradhya also tested positive.

Credit: ANI    Duration: 01:14Published

You Might Like


Related news from verified sources

'Poverty may hit 40 crore workers'

About 40 crore workers in India working in the informal economy are at risk of falling deeper into poverty during the COVID-19 pandemic crisis. The International...
Mid-Day

COVID-19 impact will remain visible in coming months, need to fight it with impetus on economy: Modi

Prime Minister Narendra Modi on Monday said the impact of coronavirus will remain visible in the coming months and masks and face covers will be part of life...
Mid-Day

Home isolation guidelines: Do's and Don'ts to follow for COVID-19 patients

Amid the rising number of coronavirus cases in India, the health ministry on Tuesday, issued home quarantine guidelines for people who have very mild symptoms of...
Mid-Day Also reported by •IndiaTimes

Tweets about this